
XVIVO Perfusion Investor Relations Material
Latest events

Q2 2025
XVIVO Perfusion
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from XVIVO Perfusion
Access all reports
Xvivo Perfusion AB, a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation. The company's primary product line are the xVivo Perflex System and the xVivo S System that combine perfusion technology with a robust cryopreservation solution to maintain viability of cells outside the body. The xVivo Perflex System is used for functional organ preservation. The company is based in Gothenburg, Sweden.
Key slides for XVIVO Perfusion


Q2 2025
XVIVO Perfusion


Q2 2025
XVIVO Perfusion
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
XVIVO
Country
🇸🇪 Sweden